Results 101 to 110 of about 694,618 (329)

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To compare the efficacy of abatacept to placebo for the treatment of relapsing, nonsevere granulomatosis with polyangiitis (GPA). Methods In this multicenter trial, eligible patients with relapsing, nonsevere GPA were randomized to receive abatacept 125 mg subcutaneously once a week or placebo, both together with prednisone 30 mg/day (or ...
Carol A. Langford   +155 more
wiley   +1 more source

Prescribing competence: The pros and cons of different methods for assessment

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Evaluating a medical graduate’s competence in rational prescribing is challenging. With the aim to guide and inspire teachers, this narrative review explores different methods that can be used to assess prescribing competence. Each method has its own advantages and disadvantages, and thus a mix of different assessment methods is needed throughout the ...
David J. Brinkman   +3 more
wiley   +1 more source

The search for atrial fibrillation and its impact on public health

open access: yesSwiss Medical Weekly, 2017
Atrial fibrillation may be clearly symptomatic and is easily amenable to state-of-the-art treatment, most importantly oral anticoagulation therapy for the prevention of thromboembolism.
Anna Lam, Eleni Goulouti, Laurent Roten
doaj   +1 more source

Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to identify distinct trajectories of lipid‐modifying medication (LMM) persistence over time and to explore characteristics associated with each pattern. Methods Using primary care data from IQVIA, we conducted a retrospective cohort study of adults prescribed LMMs between January 2015 and December 2017, with 5 years of follow‐up ...
Zhomart Orman   +12 more
wiley   +1 more source

Atrial Fibrillation [PDF]

open access: yesCardiology Research and Practice, 2013
Natig Gassanov   +3 more
openaire   +5 more sources

Balloon Aortic Valvuloplasty Prior to Self‐Expanding TAVI: The BAVSE‐TAVI Registry

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Direct transcatheter aortic valve implantation (TAVI) approach is feasible and safe compared to predilatation‐TAVI. Certain clinical and computerized tomography (CT)‐based characteristics might indicate the need for balloon aortic valvuloplasty (BAV) before TAVI, especially with self‐expanding valves.
Abdalazeem Ibrahem   +9 more
wiley   +1 more source

Long‐Term Durability of Transcatheter Aortic Valves in Patients With Bicuspid Aortic Stenosis

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Data concerning the long‐term durability of transcatheter aortic valves (TAVs) in patients with bicuspid aortic stenosis (AS) are lacking. Aims The study aims to report data on long‐term valve durability following transcatheter aortic valve replacement (TAVR) in bicuspid AS.
Yuheng Jia   +46 more
wiley   +1 more source

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

open access: yesEuropace, 2016
P. Kirchhof   +49 more
semanticscholar   +2 more sources

Radiofrequency ablation using the ThermoCool SmartTouch Catheter guided by ablation index versus antiarrhythmic drugs in atrial fibrillation treatment in China: a cost-consequence analysis

open access: yesJournal of Comparative Effectiveness Research
Aim: To evaluate the costs and consequences of two front-line atrial fibrillation (AF) treatments from Chinese healthcare system perspective: radiofrequency catheter ablation (RFCA) using ThermoCool SmartTouch Catheter guided by Ablation Index (STAI ...
Biqi Zhang   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy